Abstract:The movement towards an animal-free testing approach for risk assessment represents a key paradigm shift in toxicology. Risk assessment of engineered and anthropogenic nanoscale materials (NM) is dependent on reliable hazard characterization, which requires validated test methods and models, and increasingly on mechanistic insights into the mode of action. The properties that make NMs so advantageous for a wide range of commercial and industrial applications also pose a challenge when it comes to safety testing under in vitro and in chemico experimental settings. Their large reactive surface area makes NMs prone to interactions with assay reagents, readout signals, or intermediate steps of many test assays, leading to the potential for biased results and data inconsistencies, collectively referred to as interferences. Therefore, methods and protocols developed and validated for conventional chemicals often require adaptation and checking for reliability in NMs' toxicity assessment. This review presents the collected scientific knowledge on NMs-induced interferences for the most common in vitro toxicity assays and methods related to cytotoxicity, oxidative stress and inflammatory response evaluation. Our analysis of existing scientific literature showed that the challenge of NMs-induced interference was not explicitly addressed in more than 90% of the papers published up to 2014 reporting the safety and toxicity of NMs. In later years, increasing number of studies tackled the interference challenge in toxicity testing of NMs, which initiated exhaustive work on standardization and validation of existing regulatory-relevant in vitro test protocols and guidelines. Due to the specificity of the different NMs and the range of ways they can potentially interfere with in vitro assays, interference and fit-for purpose controls should be included for each NM type and method applied, unless label-free assays are selected. Here, we provide a decision tree to guide researchers on how to design experiments to avoid interferences during in vitro testing by taking appropriate mitigation actions and how to include proper interference controls in their experimental design where complete avoidance is not possible. The application of this decision tree will improve the reliability, comparability and reusability of in vitro toxicity data on engineered NMs or ENMs, increasing the relevance of in silico hazard data for use in risk assessment and in science-based risk governance of NMs. The approach is applicable more broadly also, to advanced materials and to hazard assessment of anthropogenic nanoscale materials such as microplastic and tyre-wear particles.

The miniaturized enzyme-modified comet assay for genotoxicity testing of nanomaterials

The Comet Assay as a Tool to Detect the Genotoxic Potential of Nanomaterials

New methodological developments for testing the in vitro genotoxicity of nanomaterials: Comparison of 2D and 3D HepaRG liver cell models and classical and high throughput comet assay formats

Assessing Genotoxicity of Ten Different Engineered Nanomaterials by the Novel Semi-Automated FADU Assay and the Alkaline Comet Assay

Genotoxicity testing of nanomaterials

Genotoxicity Assessment of Nanomaterials: Recommendations on Best Practices, Assays, and Methods

Common Considerations for Genotoxicity Assessment of Nanomaterials

Comparative and Mechanistic Genotoxicity Assessment of Nanomaterials Via a Quantitative Toxicogenomics Approach Across Multiple Species

Size-dependent genotoxicity of silver, gold and platinum nanoparticles studied using the mini-gel comet assay and micronucleus scoring with flow cytometry

Factors affecting the in vitro micronucleus assay for evaluation of nanomaterials.

Technical recommendations to perform the alkaline standard and enzyme-modified comet assay in human biomonitoring studies

Adapting the in vitro micronucleus assay (OECD Test Guideline No. 487) for testing of manufactured nanomaterials: recommendations for best practices

Measuring DNA modifications with the comet assay: a compendium of protocols

Quantifying engineered nanomaterial toxicity: comparison of common cytotoxicity and gene expression measurements

The comet assay: what can it really tell us?

Hazard assessment of nanomaterials using in vitro toxicity assays: Guidance on potential assay interferences and mitigating actions to avoid biased results

The Comet Assay for DNA Damage and Repair: Principles, Applications, and Limitations

Evaluation of the Major Steps in the Conventional Protocol for the Alkaline Comet Assay

A multi-biomarker micronucleus assay using imaging flow cytometry

Alkaline Comet Assay for Assessing DNA Damage in Individual Cells

Progress In Genotoxicity Evaluation Of Engineered Nanomaterials